EQH · Equitable Holdings, Inc.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

This transaction was executed in multiple trades at prices ranging from $48.1400 to $49.1399. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

This transaction was executed in multiple trades at prices ranging from $49.1400 to $49.1900. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Grant of employee stock option under the Issuer's 2018 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on March 1, 2019

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Total includes RSUs.

This transaction was executed in multiple trades at prices ranging from $48.57 to $49.54. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Total includes RSUs.

This transaction was executed in multiple trades at prices ranging from $48.61 to $49.54. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Total includes RSUs.

This transaction was executed in multiple trades at prices ranging from $47.57 to $48.32. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Total includes RSUs.

This transaction was executed in multiple trades at prices ranging from $47.61 to $48.32. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Total includes RSUs.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

This transaction was executed in multiple trades at prices ranging from $45.1000 to $45.6900. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.

This transaction was executed in multiple trades at prices ranging from $44.79 to $45.39. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Total includes RSUs.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Total includes RSUs.

This transaction was executed in multiple trades at prices ranging from $44.89 to $45.39. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Total includes RSUs.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Grant of employee stock option under the Issuer's 2018 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on March 1, 2019

All shares were sold at a price of $41.83, therefore only a single price is reported. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and price at which the transaction was affected.

Total includes RSUs.

Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to Issuer's incentive plan. Dividend equivalents accrue when dividends are paid on the common shares underlying the RSUs, and vest proportionally with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock.

Total includes RSUs.

Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to Issuer's incentive plan. Dividend equivalents accrue when dividends are paid on the common shares underlying the RSUs, and vest proportionally with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock.

Total includes RSUs.

Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to Issuer's incentive plan. Dividend equivalents accrue when dividends are paid on the common shares underlying the RSUs, and vest proportionally with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock.

Total includes RSUs.

Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to Issuer's incentive plan. Dividend equivalents accrue when dividends are paid on the common shares underlying the RSUs, and vest proportionally with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock.

Total includes RSUs.

Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to Issuer's incentive plan. Dividend equivalents accrue when dividends are paid on the common shares underlying the RSUs, and vest proportionally with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock.

Total includes RSUs.

Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to Issuer's incentive plan. Dividend equivalents accrue when and as dividends are paid on the common shares underlying the RSUs, and vest proportionally with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock.

Reflects acquisition of shares pursuant to the Equitable Stock Purchase Plan that have occurred since the date of the reporting person's last ownership report.

Total includes RSUs.

Dividend equivalents accrued on Restricted Stock Units ("RSUs") previously awarded pursuant to Issuer's incentive plan. Dividend equivalents accrue when dividends are paid on the common shares underlying the RSUs, and vest proportionally with and are subject to settlement and expiration upon the same terms as the RSUs to which they relate. Dividend equivalents are issued in the form of RSUs, each of which represents a contingent right to receive one share of common stock.

Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.

This transaction was executed in multiple trades at prices ranging from $41.07 to $41.09. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Grant of fully vested common stock under the Amended and Restated Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under Rule 16b-3.

Grant of fully vested common stock under the Amended and Restated Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under Rule 16b-3.

Grant of fully vested common stock under the Amended and Restated Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under Rule 16b-3.

Grant of fully vested common stock under the Amended and Restated Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under Rule 16b-3.

Grant of fully vested common stock under the Amended and Restated Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under Rule 16b-3.

Grant of fully vested common stock under the Amended and Restated Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under Rule 16b-3.

Grant of fully vested common stock under the Amended and Restated Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under Rule 16b-3.

Grant of fully vested common stock under the Amended and Restated Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under Rule 16b-3.

Grant of fully vested common stock under the Amended and Restated Equitable Holdings, Inc. 2019 Omnibus Incentive Plan exempt under Rule 16b-3.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

This transaction was executed in multiple trades at prices ranging from $42.2300 to $43.0000. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021.

This transaction was executed in multiple trades at prices ranging from $42.0600 to $42.8300. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Total includes RSUs.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025.

This transaction was executed in multiple trades at prices ranging from $42.0600 to $42.7900. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Total includes Restricted Stock Units.

All shares were sold at a price of $42.4850, therefore only a single price is reported. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and price at which the transaction was affected.

Total includes RSUs.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025.

Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vest/vested in three installments beginning on February 26, 2020

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025.

Total includes Restricted Stock Units.

This transaction was executed in multiple trades at prices ranging from $42.0400 to $42.8400. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Total includes RSUs.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Grant of employee stock option under the Issuer's 2018 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on March 1, 2019

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

Total includes RSUs.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021.

The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.

This transaction was executed in multiple trades at prices ranging from $41.2200 to $42.0700. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

Includes Restricted Stock Units and 11,011 shares acquired under the Employee Stock Purchase Plan.

The sale reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2025.

This transaction was executed in multiple trades at prices ranging from $40.0100 to $41.0000. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Total includes RSUs.